Abstract

Intravascular leads are the most vulnerable component of conventional pacemakers and defibrillators. This article discusses the current state of technology for leadless cardiac devices in the treatment of bradycardia and for reducing sudden cardiac death caused by tachyarrhythmias.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call